To further investigate this issue, we have carried out a multicentre phase II study to evaluate the impact of RRM1 and RRM2 mRNA expression in the tumours of lung adenocarcinoma patients treated with docetaxel/gemcitabine. This evidence concerns the gene RRM1 and neoplasm.